Funding for this research was provided by:
Ipsen Korea
National Research Foundation of Korea (NRF-2020R1F1A1069526)
Article History
Accepted: 21 January 2021
First Online: 2 March 2021
Declarations
:
: This work was supported by the Ipsen Korea. This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (Ministry of Science and ICT) (grant number: NRF-2020R1F1A1069526).
: Suh, H Kim, S Kim, and Han received research grants from Korea Health Industry Development Institute, Ministry of Food and Drug Safety, Ministry of Health and Welfare, National Research Foundation, Abbvie Korea, Amgen Inc, Amgen Korea, Handok-Teva, Ipsen Korea, and Pfizer Korea.
: This study was approved by the Institutional Review Board of Pusan National University (PNU IRB/2019_124_HR).
: Not applicable.
: Not applicable.
: Not applicable.
: All authors contributed to the study conception and design, data collection, data analysis, and interpretation of results. The first draft of the manuscript was written by Siin Kim and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
: Most of the data generated or analyzed during this study are included in this published article and its supplementary information files. The cost-effectiveness model that supports the findings of this study is available from the corresponding author upon reasonable request and with permission of Ipsen Korea.